TYPES AND FREQUENCY OF GESTATION TROPHOBLASTIC DISEASE by Dr Areeba Sanaullah, Dr Hamza Bhatti, Dr Muhammad Talha Bhatti
IAJPS 2019, 06 (05), 8791-8795               Areeba Sanaullah et al                     ISSN 2349-7750 
 
 
w w w . i a j p s . c o m  
 
Page 8791 
 
        CODEN [USA]: IAJPBB                        ISSN: 2349-7750 
 
  INDO AMERICAN JOURNAL OF 
 PHARMACEUTICAL SCIENCES 
                              
Available online at: http://www.iajps.com                                  Research Article 
TYPES AND FREQUENCY OF GESTATION TROPHOBLASTIC 
DISEASE 
1Dr Areeba Sanaullah, 2Dr Hamza Bhatti, 2Dr Muhammad Talha Bhatti 
1Services Hospital Lahore, 2Sughra Shafi Medical Complex Narowal. 
Article Received: March 2019        Accepted: April 2019           Published: May 2019 
Abstract: 
Objective: This research work was conducted to assess the types and rate of the GTD (Gestation Trophoblastic 
Disease) in endometrial & hysterectomy samples obtained for evaluation with the help of histopathology.  
Methodology: This research study carried out in pathology department of services Hospital, Lahore. Total 1342 
patients suffering from EC (Endometrial Curettage) & examination of total 1832 samples carried out with the help 
of hysterectomy. The collection of the samples started in March, 2009 & last sample received in April 2018. The 
ethical committee of the hospital approved the conduction of research study. The examination of the H/E stained 
slides made of glass carried out. All the patients gave verbal consent to participate in this research work. SPSS v.15 
was in use for the analysis of the collected results. 
Results: Out of total patients suffering from EC, two hundred and forty-two patients were available with 
hydatidiform mole, out of total two hundred and forty-two patients of hydatidiform mole, 69.350% (n: 172) patients 
were available with partial mole & 30.240% (n: 72) patients were available with complete mole; chorio-carcinoma 
was present in 5 patients while among 1832 samples of hysterectomy, we found only 9 patients with invasive mole. 
The occurrence of chorio-carcinoma is not same at every place and provided at 1100000 & 170000 pregnancies in 
the countries of the West and 1250 & 16000 pregnancies in the continent of Asia. 
Conclusion: The most common GTD diseases was hydatidiform mole in accordance with the findings of this 
research work.  
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INTRODUCTION: 
GTD (gestational trophoblastic disease) contains a 
band of interconnected illnesses consisting molar 
pregnancy, trophoblastic tumors of placental location, 
invasive mole & chorio-carcinoma that all have 
changing tendency for the metastasis & invasion. 
Trophoblastic tumors during pregnancy period are 
very infrequent tumors in solid shape that are mostly 
preventable even after the time of extensive 
propagation [1, 2]. Whereas the trophoblastic tumors 
in pregnancy period usually occur later molar 
pregnancy, but they have the ability to follow any 
pregnancy of female [3]. The concluded occurrence 
of GTD is different in various regions of the world. 
The authentic information of the same subject 
displays the incidence of 0.70 in the country of 
Australia [4] to 4.60 per 1000 live child births in 
Hawaii [5]. The incidence in the later country is 
much high. So, the planning of a research work 
carried out to check the endometrial curettage & 
samples of hysterectomy to find out the rate of the 
GTD in the patients of our region and this study also 
aimed to associate the results of this current study to 
the results of other previous research works.  
 
METHODOLOGY: 
Total 1342 patients with confirmed endometrial 
curettage [EC] and one thousand eight hundred and 
thirty-two samples of hysterectomy gathered during 
this study period. The collection of the samples 
started in March, 2009 to April 2018. This research 
work carried out in pathology department of services 
Hospital, Lahore. We reviewed all the information of 
these samples in this department. Ethical committee 
of Services Hospital gave the permission to conduct 
this research work. The examination of the H/E 
stained slides made of glass carried out.  
 
The identification of all the patients suffering from 
GDT carried out and after that we performed the 
determination of the serotypes of the disease. In a 
small amount of patients, the employment of distinct 
stains as Trichrome carried out to find out the 
presence of invasive mole. Initially all the 
information was present in the medical files of 
patients, we entered all the record of the patients in 
computer. The SPSS V.15 was in use for the analysis 
of the collected information. 
 
RESULTS: 
The examination of total 1342 patients with 
confirmed endometrial curettage & one thousand 
eight hundred and thirty-two samples of 
hysterectomy carried out in this research work. Out 
of total patients the diagnosis of two hundred and 
fifty-six patients with gestational trophoblastic 
disease carried out. Further classification of these 
patients carried out into subtypes depending upon the 
microscopic standard. Paradinas gave the 
microscopic criteria for the classification into their 
subtypes [6]. The most common group of age was 
consisting the patients from twenty-one to thirty year 
of age. Out of total patients suffering from gestational 
trophoblastic diseases, the most common was the 
hydatidiform mole available in 94.50% (n: 242). The 
2nd most frequent was the invasive mole present in 
3.50% (n: 9) patients & the least frequent was the 
chorio-carcinoma present in 1.950% (n: 5) patients.  
hydatidiform mole (Figure-1 & Figure-2) was most 
frequent in the patients having the age of twenty-one 
to thirty year of age. 
 
     
 Fig-1: Photomicrograph of hydatidiform mole                 Fig-2: Photomicrograph of hydatidiform mole(H/E x 200)   
(H/E x 200) 
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Invasive mole (Figure-2 & Figure-3) was very frequent in the patients having the age of thirty-one to forty year of 
age. 
        
Fig-3: Photomicrograph of Invasive mole (H/E x 100)      Fig-4: Photomicrograph of Invasive mole (H/E x 100) 
                                                                                                        
 
 
         
Fig-5: Photomicrograph of Choriocarcinoma mole          Fig-6: Photomicrograph of (H/E x 100) 
Choriocarcinoma mole (H/E x 100)      
 
Chorio-carcinoma (Figure-5 & Figure-6) was most common in the patients having the age from twenty-one to thirty 
years as available in Table-1.  
 
 
 
 
Table-I: Correlation of Frequency of GTD with Various Age Groups 
Types of GTD 
Age Groups (Yrs) Total 
15 to 20 21 to 30 31 to 40 41 to 50  
Hydatid form Mole 35.0 155.0 43.0 9.0 242.0 
Invasive Mole 2.0 2.0 3.0 2.0 9.0 
Choriocar cinoma 1.0 3.0 1.0 - 5.0 
PSTT - - - - - 
Total 38.0 160.0 47.0 11.0 256.0 
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Out of total two hundred and forty-two patients of 
hydatidiform mole, 69.350% (n: 172) patients were 
available with partial mole & 30.240% (n: 72) 
patients were available with complete mole. We 
found that the prevalence of partial mole was more 
common in the age group of twenty-one to thirty year 
of age whereas the prevalence of the complete mole 
was more frequent in the age group of forty-one to 
fifty year of age as described in Table-2. 
 
Table-II: Age Group Relationship with Frequency of Complete and Partial Mole 
Age Group 
Partial Mole Complete Mole 
No Percent No Percent 
15 to 20 yrs 22.0 8.80 11.0 4.40 
21 to 30 yrs 81.0 32.60 30.0 12.90 
31 to 40 yrs 57.0 22.90 18.0 7.20 
41 to 50 yrs 11.0 4.40 59.0 2.06 
Total 172.0 69.35 75.0 30.24 
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DISCUSSION: 
Bagshaw has highlighted the significance of a molar 
distinction from normal conceptus with the help of 
the histopathology because future of the patient is 
depending upon this distinction [7]. There is a 
confirm proof according to different findings about 
the impact of the age on the prevalence of GTDs [8]. 
In this current research work, the greatest frequency 
of GTD was present in the age group of twenty-one 
to thirty year of age with an average age of twenty-
seven years. This average age of twenty-seven years 
was according to the concluded mean age by Mungan 
[9] & Wasim [10]. The most common gestational 
trophoblastic disease was hydatidiform mole which 
was present in 94.50% (n: 242) patients of this 
research work. Out of 242 patients of hydatidiform 
mole, 69.35% (n: 172) patients were suffering from 
partial moles & patients of the complete mole were 
30.240% (n: 75) cases. Total 3.55% (n: 9) patients of 
invasive mole were available in 1832 samples which 
underwent hysterectomy examination while 1.950% 
(n: 5) patients of chorio-carcinoma were also 
available in the examination of EC.  
 
The countries of Asia reported the greatest 
prevalence of chorio-carcinoma. This prevalence 
followed by countries of Africa & Latin America 
while the lower rate of this complication was 
available in the countries of Europe, Australia & 
United Sates of America [11]. The occurrence of 
chorio-carcinoma is not same at every place and 
provided at 1100000 & 170000 pregnancies in the 
countries of the West and 1250 & 16000 pregnancies 
in the continent of Asia [12]. In accordance with 
another research work conducted in a medical college 
of Hyderabad a big city of Sindh [13], the danger of 
the chorio-carcinoma after HM is from 2% to 4% 
which is many thousand times higher than after the 
process of normal pregnancy. This research work 
also found that there is a probability for the 
occurrence of cancer after the complete mole [13].  
 
The judgement about the recovery from the 
gestational trophoblastic disease is totally depending 
upon the proper detection of the disease as well as its 
treatment. The estimation of the levels of HCG is 
very vital in the treatment as well as diagnosis of the 
disease. It is very important to use the routine 
histopathology in all the patients to detect the patients 
of GTD to find out the process of recover from this 
disease & the future outcomes on the patients 
suffering from this complication of gestational 
trophoblastic disease. 
 
 
 
CONCLUSION: 
Gestational trophoblastic disease can cause many 
complications in which most disease of GTD is HM 
as discovers by this research work. Partial mole in 
HM was the most prevalent complication. It is the 
responsibility of the health authorities to manage the 
new technology and test methods for the correct 
diagnosis and the treatment of such diseases to 
prevent the high rate of morbidity & mortality in our 
population.  
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